Smith & Nephew expands its salesforce in the US to respond to a strong hip and knee market
This article was originally published in Clinica
Smith & Nephew has benefited from a strengthening in the US orthopaedics market, which improved the company's performance in the first six months of 1999.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.